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LIST OF ABBREVIATIONS 
 
AIDS         Acquired Immunodeficiency Syndrome 
ART          Antiretroviral therapy 
BINS         Bayley Infant Neurodevelopmental Screener 
ELISA       Enzyme Linked Immunosorbent Assay 
HAZ          Height for age Z score 
HIV           Human Immunodeficiency Virus  
MSCA       McCarthy Scales of Children‟s Abilities 
PMTCT     Prevention of mother to child transmission  
SPSS         Statistical package for social sciences 
WAZ         Weight for age Z score 
WHO         World Health Organization 
WHZ          Weight for Height Z score 
GCI            General cognitive index 
HAART       Highly active antiretroviral therapy. 
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DEFINITION OF TERMS 
 
HIV infected child: a child is considered infected if antibodies for HIV persist beyond 
15 months. 
Seroreverter: a child born to an HIV positive mother whose HIV antibody test is 
negative by age 15 months. 
Infant: age from birth to 12 months. 
Preschool age: chronological age of between 2 and 5 years. 
Intelligence: measured by Kaufman`s short form of McCarthy Scales of Children `s 
Abilities and reported as General Cognitive Index (GCI). 
Neurodevelopment impairment: Refers to conditions which are characterized by either 
developmental delay or regression of previously acquired milestones. 
BINS level of risk for developmental delay: Categorized as low, moderate or high risk 
according to summary score. 
Cognitive impairment: a GCI >1 SD below the average score (< 84). 
Screening: a test conducted on a population to identify those at risk. In this study those at 
risk are sent for definitive diagnosis and intervention of the particular type of disability. 
Morbidity: refers to the occurrence in the previous 3 months of any of the following 
illnesses: cough, diarrhea, fever, ear discharge, vomiting or admission to hospital with 
any other diagnosis. 
WHO paediatric clinical staging of HIV / AIDS: for children with confirmed HIV 
infection and based on the presence of various symptoms: Stage 1= asymptomatic; Stage 
2= mild symptoms; stage 3=advanced symptoms; stage 4 =severe symptoms. 
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ABSTRACT 
Background and purpose. The relationship between paediatric HIV infection and 
neurodevelopment has been studied largely in developed countries even if the burden of 
paediatric HIV is in Sub -Sahara Africa. This study assessed cognitive outcome at 
preschool age in Zimbabwean children, enrolled from a national PMTCT program, with 
vertically transmitted HIV type 1 infection who had been followed up for 5 years. 
Methods. We assessed cognitive function in 278 preschool children with Kaufman short 
form of McCarthy Scales of Children`s Abilities (MSCA). Four groups were identified: 
25 with HIV infection, 94 HIV negative born to HIV positive mothers (seroreverter), 126 
HIV negative born to HIV negative mothers (controls) and 33 with unknown status. All 
children had been previously screened in infancy for neurodevelopment using Bayley 
Infant Neurodevelopmental Screener [BINS]; 115 had received prophylactic single dose 
Nevirapine at delivery, but none were on antiretroviral treatment. 
Results. Cognitive impairment was observed in 24 children (8.6%) without significant 
difference between the groups. The family income of less than 30 US dollars per month, 
having a teenage mother and renting a house was associated with cognitive impairment. 
Mean General Cognitive Index(GCI) subtests scores were significantly lower between 
seroreverter and HIV negative children in specific subtests representative of verbal, 
perceptual performance and quantitative performance.HIV infected children were 
significantly more stunted , had more skin disorders, and lymphadenopathy compared to 
their uninfected peers. Maternal age was predictive of lower GCI scores. Correlation 
between BINS high risk score and GCI was observed between the ages 3 to 4 months. 
 Conclusion. The Kaufmann short form of MSCA is a simple cognitive screening tool for 
preschool children, however it should be complemented by a good neurodevelopmental 
screening tool in the first year of life.HIV infected children who survive to preschool age 
did not manifest lower cognitive scores than established child norms. Chronic 
malnutrition as indexed by stunting was associated with poor cognitive function at 
preschool age. BINS if performed in the first 6 months of life, was predictive of later 
cognitive performance particularly in HIV infected children. Therefore comprehensive 
interventions addressing early diagnosis and treatment for both childhood HIV and 
malnutrition could result in significant improvement in cognitive function. 
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CHAPTER. 1    INTRODUCTION 
 
The period from conception to the first six years of life have been shown to set a basis for 
the coping skills in learning, behavior and health in adulthood(1). In developing countries 
it was estimated that more than 200 million children under the age of 5 years do not reach 
their cognitive developmental potential due to preventable risk factors  such as  
infections, malnutrition and inadequate cognitive stimulation(2).These early adverse 
childhood experiences influences brain development and have social, economic and 
political ramifications for the future(3). 
 
Globally there are 2.5 million children younger than 15 years living with HIV/AIDS and 
90% acquired the infection from their mothers during pregnancy, labour, delivery or 
postnatally through breast feeding. An estimated 500 000 new infections in children less 
than 14 years occurred in 2006 and at least 90% live in Sub-Sahara Africa(4). Due to 
premature deaths in the adult population the number of AIDS orphans and child –headed 
households is also increasing(5). The relationship between paediatric HIV infection and 
neurodevelopment has largely been studied in developed countries(6) when the burden of 
paediatric HIV is in Sub -Sahara Africa. HIV type1 infection is associated with poorer 
child neurodevelopment. Conflicting evidence exist on the prevalence of 
neurodevelopment impairment in HIV exposed and infected children(7-10). The different 
methods used by various researchers in equally diverse populations dilute the 
generalisability of the results(11-13). 
 
Zimbabwe, once the bread basket of southern Africa has one of the highest adult HIV-1 
seroprevalences in the world. In 2004 data from the national surveillance system 
estimated the adult prevalence at 21% (14). In response to HIV / AIDS Zimbabwe rolled 
out  the Prevention of Mother to Child transmission of HIV (PMTCT) program according 
to HIVNET 012 recommended guidelines(15). In the absence of HIV prevention 
measures, approximately 35 % of children born to HIV positive mothers will contract the 
virus and are at risk of poor neurodevelopmental outcomes. This study is important 
because there is a dearth of knowledge on the relationship between perinataly acquired 
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HIV infection and cognitive abilities at preschool age in African children. Infected 
children are surviving beyond infancy even in resource limited countries. Disability 
among children was estimated at 2 % in Zimbabwe(16), but no documented evidence 
exist on the contribution of HIV-1 . 
 
This sub-study is part of a larger study on mother to child transmission of HIV(17). The 
children born to mothers of the initial cohort have been followed up from birth to assess 
risk for neurodevelopmental impairment during infancy and at preschool age. The aim of 
this study was to compare cognitive function at preschool age in a paediatric sample of 
infected and uninfected children born to mothers who participated in the national PMTCT 
program. The information from this study may contribute to existing knowledge on the 
subject of child development in developing countries as well as aid in formulating 
guidelines in the screening for neurodevelopmental impairment and care of HIV exposed 
children. 
 
1.1 OBJECTIVES 
 
1.1.1 Main objective 
 The main purpose of this study is to describe cognitive performance (according to     
 McCarthy Scales of Children `s Abilities), at preschool age, in children born to HIV 
infected and uninfected mothers who participated in the national PMTCT program. 
 
1.1.2    SPECIFIC OBJECTIVES: 
1) To characterise cognitive performance using the McCarthy Scales of Children `s 
Abilities in a cohort of children. 
2) To identify predictors of cognitive impairment at preschool age in these children. 
3) Compare cognitive function at preschool age with early neurodevelopment outcomes 
according to Bayley Infant Neurodevelopment Screener (BINS). 
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CHAPTER. 2           BACKGROUND INFORMATION 
 
2.1   CHILD DEVELOPMENT 
Child development involves the acquisition of physical, cognitive, motor, social, 
language and sensory integration skills at predictable stages. This is necessary for later 
age- appropriate interaction with the environment. Exposure of the developing child to 
biological and psychological factors may result in undesirable alteration in the global or 
specific cerebral structure and function(18). Functional limitations that result from 
disorders of central nervous system describe neurological impairment. In children it is 
important to monitor early development because although the developing brain is 
vulnerable to insults, unlike in adults, recovery is possible with early diagnosis and  
interventions, averting permanent disabilities(19).Therefore screening children ascertains 
if a child has acquired developmental milestones appropriate for his or her age. 
 
2.1.1   RISK FACTORS FOR POOR NEURODEVELOPMENTAL OUTCOMES 
Evidence abounds that early years of development from conception set the base for 
coping skills in learning, behavior and health throughout adult life(1). Brain 
differentiation occurs in a chronological order starting with cell proliferation, migration, 
synaptic connection, myelination and pruning (20) and can be affected by a variety of 
biological and psychological factors at each  developmental stage. Established biological 
risk factors include infections, malnutrition, neurotoxins and micronutrient deficiencies. 
The timing of the injury has consequences on the pattern of neurological impairment(10). 
 
 2.1.1.1   Environmental and psychological factors 
 The family unit usually forms the first immediate environment that a child is reared in. 
The relationship between the quality of home environment and later achievement in 
school is well documented(21-24). The quality of parenting a child receives namely 
“cognitive stimulation,  care-giver sensitivity,  responsiveness to the child and caregiver 
`s affect” influences cognitive and social competence(25). Simple touch has been 
suggested to exert long lasting cognitive effect in preterm infants through stimulation of 
cortical growth and synaptic proliferation(26). Studies  done in the developed countries 
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reported higher cognitive function in children who received additional stimulation 
compared to those who did not(18). A study from South Africa also reported non 
cognitive benefits such as improvement in social behavior, confidence and positive 
affect(25). In most of the studies designs maternal responsiveness and sensitivity were 
not controlled for, making it difficult to attribute the improvement to cognitive 
stimulation only. 
 2.1.1.1.1   Child stimulation and cognitive function 
Poverty in the home has adverse effects on the child development. Poverty is correlated 
with increased maternal stress or depression and inadequate child stimulation in the 
home(2). Studies demonstrated that the electrical brain activity of newborns of depressed 
mothers show reduced ability to learn from the environment(27).Maternal depression is 
linked to poor cognitive and language development in the children (27).Interventions to 
diagnose and treat maternal depression may reduce cognitive disorders in their children. 
In the context of HIV infection, maternal mental health disorders will compromise the 
parent –child interaction influencing cognitive stimulation. 
 
    2.1.1.1.2     Home environment 
The characteristic of the home environment also has an impact on child cognitive ability. 
Unfavorable home environmental factors such as unstable caregiver, maternal alcohol or 
drug abuse, poverty or maternal low education put children at risk for developmental 
dysfunction(21;24). The physical environment exerts an important effect on neuronal 
development. Children with fewer stimulating play materials in the home were found to 
be more at risk for low intelligence later in life than children with more stimulating play 
materials(21). Contaminants in domestic water such as lead, manganese and arsenic have 
been documented to have detrimental neurological outcomes. In a meta analysis by 
Lanphear non toxic level of lead exposure was associated with decrement in Intelligent 
Quotient(28) . 
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2.1.1.2      Biological factors 
     2.1.1.2.1      Growth and development 
Growth and development in children is influenced by a multitude of interlinked risk 
factors. Intrauterine growth restriction (IUGR), birth weight of <2500 g at > 37 weeks 
gestation has been demonstrated to be associated with lower developmental levels by 
school going age in a European cohort(29). The neurophysiological explanation is a 
reduction in neuronal cell number, size, with an overall lower brain weight  (30). In 
paediatric HIV, when other risk factors for poor growth such as social environment are 
considered, faltering growth parameters may be used as markers of  HIV disease 
progression(31). Those with growth failure have earlier onset of neurodevelopment 
delay(32;33). Mechanisms proposed to explain the growth failure in HIV include 
inhibition of growth hormone-releasing factor, decreased peripheral sensitivity to growth 
hormone and decreased levels of insulin like growth factors(34). 
 
 Reduced head circumference for age (an indirect measure of  brain size assessed by 
measuring the occiputofrontal circumference) has been associated with developmental 
delay(35). In a study to investigate the relationship between head circumference at birth 
and later intelligence quotient(IQ) in Chilean school age children, an association was 
found between low head circumference and decreased IQ by school age(35). In a review 
article by Wachsler-Felder, exposure to perinatal HIV infection was suggested to be  
associated with reduced brain growth and neurological decline in HIV infected 
children(36).The detrimental effect of HIV on central nervous system  was maintained to 
24 months of age in a study by Macmillan C et al(37). In Zimbabwe the underlying 
causes for developmental delay still need to be explored in the context of a developing 
country. Monitoring children‟s growth parameters is therefore essential to identify those 
that digress from the optimal growth curves and institute timely intervention. 
 
    2.1.1.2.2     Nutrition and cognitive development 
  Micronutrients deficiencies such as iodine, iron, zinc and n-3 fatty acids also affect 
central nervous system development through various patho- physiological mechanism 
.Iron deficiency in infants  has been suggested to be associated with poor mental and 
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motor performance which improves on supplementation of iron(18). A survey conducted 
in Zimbabwe in 1998 estimated the prevalence of iron deficient anaemia in preschool 
children at  almost 20%.(38). There is lack of information on the contribution of iron 
deficiency and other nutrients to preschool cognitive performance in Zimbabwe. Families 
living with HIV tend to divert economic resources to the care of the chronically sick 
parent leaving little for nutritional needs. 
 
2.1.2       HIV AND COGNITIVE DEVELOPMENT  
HIV virus is neurotrophic and affects children cognitively and developmentally due to the 
susceptibility of their immature immune and central nervous system (CNS). In perinatally 
infected children cognitive, motor and behavioral disorders have been show to be related 
to the direct infection of the CNS by the virus as the disease progresses. The virus targets 
areas  responsible for  tactile, visual, expressive speech, memory and intellectual 
processes, rhythm, acoustic-motor and writing(36). There is inhibition of myelination and 
associate fiber development in the frontal and prefrontal areas which results in 
neurological deficits in processing speed, visual motor integration and sustained 
attention. Nozyce et al documented that mental and motor impairments appear more in 
HIV infected children who develop a serious AIDS defining illness in the first 2 years of 
life(39). Fishkin and Blanchette investigated preschool and school age children 
respectively. There were no gross cognitive differences between infected and uninfected 
peers from similar backgrounds(8;40). Older children tend to exhibit motor impairments 
characterized by progressive corticospinal tract signs with loss of previously acquired 
motor milestones. Paediatric HIV and its influence on child development can be 
prevented. PMTCT interventions may prevent perinatal transmission of HIV by up to 50 
% in a breastfeeding population (15). 
 
 
2.1.3 ANTIRETROVIRAL TREATMENT AND NEURODEVELOPMENT 
           The interaction between perinatal HIV 1 infection and ARV prophylaxis on 
neurodevelopment is largely unknown. Studies have documented the pharmaco-dynamics 
of the antiretrovirals on the central nervous system, but few have looked at the long term 
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the impact of ART prophylaxis or treatment on child neurodevelopment.  A study 
comparing neurodevelopment outcomes in a Canadian cohort of HIV uninfected children 
exposed to combination highly active antiretroviral therapy in pregnancy versus those not 
exposed did not establish any difference in developmental outcomes(11). Other studies 
have suggested clinical improvement when antiretrovirals are started early in the 
treatment of HIV infection.  
          
           2.1.4      PURPOSE OF NEURODEVELOPMENTAL SCREENING  
Neurodevelopment screening aims to identify children at risk of developmental 
impairment or delay and refer them for further assessment(41;42). 
The exact nature of neurological deficits in children exposed to HIV is still unclear 
because previous studies had a wide variety of methodological problems that influenced 
interpretation. Different screening tests were employed since there is no gold standard 
test(43;44). Within some studies the form of the same test differed between age groups 
complicating interpretation(7;11). The screening tests used so far in African populations 
have been translated from English bringing in the issues of cultural bias, validity and 
reliability. Sadly routine screening for developmental delay is not practiced widely in 
resource limited settings despite the ability to identify infants at risk who may benefit 
from referrals for assessment and early therapy. 
 
2.2       ZIMBABWE, COUNTRY PROFILE 
2.2.1     Geography 
Zimbabwe lies in southern Africa sharing borders with Zambia in the north, Mozambique 
in the east, South Africa on the south and Botswana in the south west. It has one of the 
highest HIV prevalence rates in the Sub-Sahara region. The landlocked country stretches 
over 390 759 square kilometers and is inhabited predominantly by Africans:  Shona 82%, 
Ndebele 14% and other ethnic groups 2%. Caucasians and Asian constitute the remaining 
2%. Zimbabwe is divided into 10 administrative provinces, which are further divide into 
districts, wards and then into smallest units, villages in rural areas or ten house units in 
towns.  
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2.2.2   Population Demographic Characteristics 
The population of Zimbabwe was 13 076 000 in 2002 (Population census 2002). Females 
constituted 51.2% and males 48.8%. Over 70% of the population resides in the rural areas 
and population density is estimated to be 32.3 per square meter. Children under 15 years 
of age make up 45 % of the population. The projected annual growth rate is 3.7% and the 
average fertility rate is 4.5 per woman. 
The health parameters for the country are poor. The infant mortality rate is estimated at 
68 per 1000 live births and life expectancy is 37 years for men and 34 years for women. 
However, the literacy rate is about 90%, amongst the highest in Africa(45). 
 
2.2.3     Economy 
Zimbabwe, once the bread basket of Southern Africa is going through an economic crisis. 
More than 80% of the population is living below the poverty line. A myriad of factors are 
been implicated in the economic meltdown including a succession of droughts, land 
reforms, and ill conceived government policies. The International Monetary Fund 
estimates the country `s inflation at above 160 000%, the highest in the world for a 
country which is not at war. The Zimbabwe gross national product (GPN) has stalled. 
The main sources of revenue are mining, tourism, and commercial farming (Zimbabwe 
Financial Gazette 2008). 
2.2.4    Health infrastructure 
At the time of this study, the health system in Zimbabwe had collapsed due to perennial 
poor funding, poor communication infrastructure, drug and health personnel shortages. 
Historically the public sector, through the Ministry of Health and Local government 
provided health services to both rural and urban areas. A four tier referral system still 
exists where the first level is the primary health care centre, the second the district 
hospital or mission, the tertiary the provisional hospital and the quaternary level the 
central hospitals. On average an individual lives within 8 miles of a health centre. A total 
of 106 government hospitals and 1500 primary health care clinics used to provide 
comprehensive services in maternal and child care, curative services and   environmental 
health promotion. 
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2.2.4.1   Child follow-up clinic 
Immunization, growth monitoring, opportunistic infection prophylaxis and nutritional 
counseling are some of the services offered at the maternal and child health clinics. In the 
first 2 years of life recommended vaccines are provided at birth, 3, 4, 5, 9 and 18 months. 
Concurrently gross motor development is assessed by enquiry. Those perceived as 
developmental delayed are referred to the next referral centre .The period between 18 to 
60 months is quiescent as there is no scheduled interaction between health services and 
children occurs unless the children are unwell. Developmental monitoring and screening 
is not offered as part of follow up of children.  
 
2.2.5    Epidemiology of Paediatric HIV. 
Paediatric HIV is acquired mostly through MTCT. Estimated prevalence of  HIV in 
women attending urban antenatal clinics was 31.1%  in a study conducted in Harare, 
Zimbabwe (46). United Nation Children`s Fund estimates that 160 000 Zimbabwe 
children under the age of 14 are infected with HIV and that there are at least a million 
orphans whose parents have succumbed to HIV infection. Although the government has 
rolled out a national PMTCT program, only 10 % have access to services. No coordinated 
screening programs are in place to identify children early who have faltered from their 
growth and developmental trajectory.  
 
2.2.6   Study Area 
The study was conducted in the outskirts of Harare, Zimbabwe at 2 peri-urban areas of 
Chitungwiza and Epworth. Chitungwiza city is located 15 kilometers southeast of the 
capital of Zimbabwe, Harare. It is a residential dormitory for the capital and was formed 
in 1978 by amalgamation of three townships Zengeza, Seke and St Marys. It has a young 
population of 400 000. Epworth is located south of the capital; within a 20 kilometer 
radius .It is administered by a rural administrative board.  
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Figure 1 Map showing the cities of Harare and Chitungwiza, Zimbabwe. 
 
©GraphicMaps.com 2008 
 
 
STUDY SITES 
The clinics of St Marys, Seke and Epworth were selected as study sites based on the 
number of patients attending the health centers and feasibility of carrying out clinical 
research. The clinics offer a wide range of services and are used mainly by the low 
income population 
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CHAPTER.3     METHODOLOGY 
 
3.1    STUDY DESIGN 
This is part of an ongoing prospective study that has followed up mothers and their 
children from birth to the present day (17). Briefly, the primary study examined the role 
of sexually transmitted infections in Mother to Child transmission of HIV type 1 in 
Harare Zimbabwe during the period 2002 to 2004. The children born to women who 
participated in the study were assessed during infancy for neurodevelopment outcomes at 
scheduled intervals from 3 months to 12 months using the Bayley Infant 
Neurodevelopment Screener (BINS). A level of risk for neurodevelopmental delay was 
assigned to the children based on the BINS score.  
 
3.2    STUDY POPULATION 
 Participants in this study were children who successfully completed at least 1 neuro 
developmental assessments by BINS during the follow up of one year and had complete 
longitudinal data for at least 3 years. In the  primary study, both HIV positive and HIV 
negative pregnant women who had gone through the national PMTCT program at 36 and 
38 weeks of gestation,  who also had a documented HIV result from the national program 
,were enrolled. The pregnant women were investigated for incidence of HIV type 1 and 
reproductive tract infections. The infants were followed up initially at scheduled visits at 
6 weeks, 4 months, 9 months, 12 months and every 6 months thereafter. 
3.3     SAMPLE SIZE 
The sample size for the children was derived from calculations for the primary study. The 
calculated sample size for the pregnant women was based on  31 % HIV prevalence  
among pregnant women, 90% power to detect a 1.6 fold difference in HIV infection rates 
between the two groups, using a 2 tailed test with = 0.05, and allowing for a 25% loss to 
follow up. The estimated sample size was therefore 300 HIV positive women and 600 
HIV1 negative women. For every HIV positive woman enrolled in the follow-up study, 
two HIV negative women were selected as controls, matched for age +2 years, parity and 
the area of residence.  The initial study design was modified mid way to conveniently 
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enroll more HIV -1 infected pregnant women as their numbers were very few. During the 
study period 2002 to 2004 a total of 1050 pregnant women were enrolled with 496 HIV 
infected and 554 HIV uninfected. From a total of 1044 live births, 644 infants were 
assessed with the BINS instrument at least once in the first 12 months of age and 
therefore enrolled into the paediatric cohort. For the present study those who fulfilled the 
inclusion criteria were enrolled from the existing paediatric cohort. 
3.3.1    INCLUSION CRITERIA 
1) Participants from the primary study with at least one neurodevelopmental assessment 
by Bayley Infant Neurodevelopmental Screener (BINS). 
2) Children who are aged 3 ½ years and above. 
For children less than 3 year the MSCA is not reliable in assessing cognitive function 
compared to the Bayley Scales of Infant Development assessment tool(42). 
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3.4 FOLLOW UP OF CHILDREN AND ASSESSMENT 
 From the initial cohort of 644 children, 23 declined to participate for various reasons, 
150 had relocated to a distant region, 58 had died, and 126 could not be traced, resulting 
in 287 who agreed to participate (Figure 2).  
A total of 278 preschool children had complete examination (Figure 3). 
 
Figure 2 Follow up pattern at preschool age from the original cohort of 644 children. 
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Figure 3   Flow chart showing the number of children followed up to preschool age. 
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278 preschool 
Children  
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3.5 PROCEDURES 
    3.5.1   Recruitment  
Children were invited to the study sites after a field worker had visited each eligible 
household to inform the families about the study and request participation. 
The study aims and procedures were explained to each mother or close relative 
accompanying the child. Written consent was obtained.  They were assured that 
withdrawal from participation in the study would not interfere with access to treatment or 
other services for their child. 
 
   3.5.2 Clinical follow up 
Baseline data on demographic factors, medical history, and nutritional history were 
collected during interviews with primary care givers using a structured interview 
questionnaire. Clinical and psychometric examinations were done by the medical staff 
that comprised 2 paediatricians and a research nurse.  At each follow up visit, a history 
and physical examination of the children was performed. Anthropometric measurements: 
height, weight and head circumference were taken.  Inquiry into the children‟s health 
complaints and home environment were made. If children had an acute illness, the testing 
was deferred until they were well. Medical care was provided to those with acute 
illnesses. 
 
  3.5.3 Definition and Classification of HIV -1 infection 
The paediatric HIV clinical staging was assessed according to WHO algorithm(47). 
Those meeting the criteria for starting antiretroviral treatment were referred to tertiary 
hospitals where comprehensive monitoring and treatment with antiretroviral therapy for 
children is currently centralized. 
 According to the primary study protocol, laboratory criteria for diagnosis of HIV 
infection in the children was the detection of antibodies to HIV -1 infection in venous 
blood at the age of 15 months or beyond. HIV testing was performed using Abbott 
Determine HIV1/2 and Trinity BiotechHIV1/2 rapid tests. Positive tests were confirmed 
by ELISA, Vironostika HIV Uni-form11(Organon Teknika, Boxtel Netherlands). If the 
test was positive, the child was classified as HIV infected and if negative as HIV 
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uninfected. Laboratory measures of immune status such as CD4 and viral loads were not 
available at the time of the initial cohort. 
For most children growth was assessed by measurement of weight (in kilograms) using a 
Salter weight scale (model Salter 9145 tracker scale) and height on a height board. Head 
circumference (cm) was measured by a non stretchable tape measure. 
 
  3.5.4 Neurological status 
The neurological assessment included evaluation of mental status, cranial nerves, muscle 
tone, sensation, upper and lower extremity reflexes, balance, and rapid alternating 
movements. Power was tested by asking each child to push and pull the examiner`s upper 
limbs and opposing their movements. 
All sensation tests were be performed with the child‟s eyes closed. 
Pain was elicited by lightly touching the child with a single use disposable pin. Heat and 
cold tested with objects with a relatively higher or cooler temperature to the child‟s body 
temperature. Vibration was not assessed in this cohort of the children. Presence of 
persistent neurological abnormality was classified as abnormal. 
3.6 COGNITIVE ASSESSMENT AT PRESCHOOL AGE 
The Kaufman`s short form of the McCarthy scales of Children `s Abilities (MSCA) was 
administered cross sectional to determine the cognitive development of the children. 
Trained research staff blinded to the HIV status of the child, assessed the children in the 
presence of the parent or guardian. Children who performed poorly on any one of the 6 
test items were invited for retesting within a week of the first test. They were examined 
only on the subset not performed adequately to limit practice effects. Efforts were made 
for the child to be examined by the same examiner. 
 
   3.6.1   Description of The Kaufman`s short form of the McCarthy scales of    
              Children `s Abilities (MSCA) 
The McCarthy Scales of Children`s Abilities is an assessment tool that was developed for 
children of ages 2 ½ through to 8½ years. It assesses children‟s present level of 
functioning in intelligence and motor ability with the aim of identifying possible 
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developmental delay in different skill areas. It consists of 18 subsets of cognitive and 
motor ability. Weighted raw scores are grouped to yield scores in 5 global areas of 
function: verbal, perceptual-performance ,quantitative, memory and motor .The weighted 
raw scores from  verbal perceptual –performance and quantitative are converted to an age 
–related scaled score or index, and are then combined to yield a General Cognitive Index 
(GCI) . The mean for the GCI is set at 100, with a standard deviation (SD) of 16. Index 
scores for the 5 domain scales have a mean of 50 with a SD of 10 as the optimum score. 
Items from the verbal, perceptual-performance and quantitative are content oriented, with 
no subset from one domain contributing to the score of another domain. The memory and 
motor domains are process oriented and subsets overlap with verbal, perceptual-
performance or quantitative domains. The GCI of the MSCA was correlated with the 2 
standardized diagnostic tests for cognitive ability namely the Stanford -Binet Intelligent 
test and the Wechsler Preschool and Primary Scale for Intelligence. The GCI correlated 
.81 with the Stanford –Binet Intelligence test and ranged .62 to .71 with the WPPSI. 
Correlation between a brief version of the MCSA, the Kaufman `s short form of the 
MCSA and the Stanford-Binet Intelligence scales 4
th
 Edition was .91. 
 
For this study the Kaufman`s short form of the McCarthy Scales of Children`s Abilities 
was adopted in accordance with the MSCA manual instructions. It consists of a six-test 
abbreviated version of the General Cognitive Scale and gives a proportional 
representation to the verbal, perceptual-performance, quantitative and memory scales 
which correlates substantially with the entire McCarthy scales. It serves as a screening 
instrument for a wide variety of mental functions and is brief to administer and score(20 
to 25 minutes).The six tests items in the Kaufman short form are puzzle solving, word 
knowledge, numerical memory, verbal fluency, counting and sorting and conceptual 
grouping. The reliability of the estimated GCI was .90 in the standardization sample and 
was .71 in this sample. 
In this study cognitive ability  was expressed as a GCI  score based on age specific 
normative data  among American children and classified as follows: GCI  > 120 superior  
intelligence; 85 to 119 ,average to high  average; < 84  low intelligence. All children 
scoring below 64 were aggregated to 64. 
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Modifications 
Based on a pilot study (n=21), culturally appropriate modifications to some of the test 
items were made to make the battery of tests applicable. Test content and format was 
preserved .Test items were examined individually to establish which pictures and items 
were recognizable and to evaluate clarity of instructions. As a result of piloting we 
substituted some items with familiar materials. Translations of all instructions, objects 
and pictures were made into the local Shona language. During the assessments 
establishing rapport with the participants was emphasized. Detailed preparatory 
instructions and explanation of errors and successes seemed to enhance performance on 
the children. All assessments were carried out in Shona by examiners who were fluent in 
the language in offices situated at the quiet end of an outpatient department. 
 
Procedures to enhance validity and reliability of data 
Data were reviewed regularly to optimise quality control and inter-observer reliability 
specifically with the scoring criteria. Inter-tester reliability among study examiners was 
maintained by centralized training of all the project examiners by a senior clinical 
psychologist. As the MSCA was administered only once, the test retest measure was not 
assessed. Inter- rater reliability was enhanced by strict adherence to the scoring system 
Since this instrument has not been standardised in Shona speaking children, scores based 
on American test norms may not necessarily be equivalent for Zimbabwean children. 
 
  3.6.2  Baileys Infant Neurodevelopment Screener (BINS)  
The Baileys Infant Neurodevelopment Screener (BINS) is a screening tool designed to 
identify infants between the ages of 3 to 24 months at risk for developmental delay or 
neurological impairment. Four global conceptual areas of ability are assessed: i) basic 
neurological function/ intactness; ii) expressive functions; iii) receptive functions and iv) 
cognitive functions. The 4 conceptual areas of ability can be used to determine if the 
neurodevelopmental impairment is global or specific.  The BINS is age specific and 
consists of 11 13 items depending on the age of the child. Each item is scored as optimal 
or none optimal and the optimal responses are totaled to yield a summary score. An 
optimal finding has a higher predictive value for later positive outcome. The summary 
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score reflects the child‟s level of risk for developmental delay or neurological 
impairment, which is classified as one of the three risk groups: low, moderate, and high.  
In addition the BINS were analysed as a dichotomous variable HIGHRISK and 
LOWRISK, according to cut off points presented in the BINS manual  
   
3.7 Definition of variables 
Dependent (Outcome) variable: Intelligence: As measured by MSCA the individual‟s 
ability of solving problems and process information.  
Independent (explanatory) variables: 
1. Child‟s care giver `s socioeconomic status 
2. Child `s demographic characteristics 
3.  Child `s HIV sero-status  
4.  Child `s nutritional status 
5. Child `s health status 
6. BINS  neurodevelopment level of risk at infancy 
 
3.8    DATA PROCESSING 
The data were entered into a prepared master sheet daily in the field, cleaned, checked 
and corrected for inconsistencies. 
 
3.8   DATA ANALYSIS 
Only children with complete cognitive assessment data were included in the analysis. 
Cognitive function was classified according to the sum of the weighted scores in the six 
tests items of the Kaufman short form: puzzle solving, word knowledge, numerical 
memory, verbal fluency, counting and sorting and conceptual grouping. The General 
Cognitive Index (GCI) was computed from the total score. A score of 84 and below (- 1 
SD below the mean) was selected as the cut-off point for cognitive impairment in this 
cohort. All analyses were conducted using SPSS for windows (Rel 12.0.1, 11 Nov 2003, 
Chicago, SPSS, Inc). Statistical analysis consisted of comparisons of proportions using 
the Chi square and Fischer `s exact tests for categorical data. Comparison of group 
averages was based on analysis of variance (ANOVA) when normality of data was 
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assumed otherwise Kruskal Wallis test was used (48;49). Pearson correlation was used to 
determine the association between the BINS scores and MSCA GCI scores. All tests were 
2 tailed. A P-value of <0.05 was be considered statistically significant and only 
calculated for non missing data.  Logistic regression was employed to generate odds ratio 
and predict cognitive impairment. All variables were categorized in the multivariate 
model. Maternal age was categorized as <20 or > 20 years. Maternal education was 
categorized as “less than primary school” if she did not complete 7 years of school, 
“primary” if she completed 7 years and “secondary” or higher if she had more than 7 
years education. Maternal income was categorized into < 30 US dollars or >30 US 
dollars. Birth weight was categorized into < 2500 rams (low birth weight), > 2500 grams 
(normal birth weight), Height, Weight,head circumference were categorized into  
abnormal (< 2 SD of mean for age and  normal( > SD of mean for age). The number of 
surviving HIV infected children in this sample determined the relatively small sample 
size (n=25). 
3.9    ETHICAL ISSUES 
  4.0  Approval 
The study was approved by the Norwegian regional committee and Medicine Research 
Council of Zimbabwe. Ethical concerns in this study included the involvement of 
children in research, informed consent from minors, confidentiality, beneficence and 
standard of care. Written consent for the study was obtained on behalf of the children 
from their primary care-givers. The purpose and procedures of the study were explained 
in the local language. They were informed that participation was voluntary and that 
refusal would not result in any penalty or loss of benefit they previously enjoyed. They 
were informed of their right to withdraw from study at any time. 
 
  4.1 Confidentiality 
Due to the sensitive nature of some of the questions asked, strict confidentiality was 
maintained throughout the study. Each child already had a unique study identification 
number. All data were be collected and analysed according to these numbers. The coded 
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numbers identifying study participants and all records were locked in a cabinet file. Any 
links connecting participants‟ identification numbers to other identifying information was 
stored separately in a locked cabinet with limited access. 
 
  4.2 Beneficence 
Children diagnosed to have developmental delay or to have a medical condition were 
referred for appropriate assessment and diagnosis. A study paediatrician provided free 
consultation and treatment for opportunistic infections. HIV infected children satisfying 
criteria for starting antiretroviral were referred to the central hospital where 
comprehensive care was available. Attempts were made, within the limitations of the 
available resources to facilitate that the best available treatment was secured for those in 
need. 
 
  4.3 Compensation  
The mothers and children were compensated for the transport costs incurred when they to 
came to the study clinic. 
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CHAPTER.4    RESULTS 
4.1      FOLLOW UP  
    4.1.1 COMPARISON OF ENROLMENT CHARACTERISTICS BY FOLLOW UP   
             PATTERN FOR 644 CHILDREN IN THE INITIAL COHORT   
 
At 5 years follow up, of the 644 infants assessed for neurodevelopment during the ages 3 
to 15 months, 58 were reported dead, a further 299 were lost to follow resulting in 287 
who  consented to participate.    
The children in the 3 groups were comparable at baseline except for usage of Nevirapine 
prophylaxis at delivery and presence of neurodevelopmental high risk in infancy which 
was more frequent in the group of children who died. 
 
 
Table 1 Comparison of enrolment characteristic between children who participated in the 
follow up study, those lost to follow up or dead. 
                                                                          Participants          Loss to follow-up
ş
             Dead                             P value  
  Infant variable                            N=287                 N=299                               N=58 
                                     
  Birth weight ,mean Kg± SD                        3.1± 0.4            3.06± 0.4                          3.06 ±0.4                              0.776 
  Male sex                                                      129  (44.9)       140/261 (53.6)                   28 (48.3)                              0.127 
  Nevirapine prophylaxis at delivery            128(44.6)          92 (30.8)                            30 (51.1)                              0.001* 
  Neurodevelopment high risk  in infancy     13 (4.5)            13 (4.3)                               8 ( 13.8)                              0.01
α
 
* participants versus those lost to follow up or died  
α  participants and those children that died 
ş participants who either refused to further take part in the study, moved to a distant province or whose whereabouts 
could not be verified. 
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Comparison of maternal characteristics at baseline between the study participants and the 
rest of the children showed no significant difference in relation to marital status, 
employment, years spent in formal education and occupation. Mothers lost to follow up 
were more likely to be HIV uninfected, younger, have less number of living children and 
less compliant to nutritional supplementation with Omega 3 (Table 2). 
 
Table 2 Comparison of maternal enrolment characteristic between children who 
participated in the follow up study, those lost to follow up or died. 
 
                                                                     Participants               Loss to follow-up
 Ω
             Dead                               P value  
 Maternal     Variable                             N=287                      N=299                                  N=58    
Maternal HIV-1 sero status                  
     Negative                                             139 (48.4)                  167 (55.9)                       17(29.3)                               0.001* 
     Positive                                               148/287 (51.6)           132/299 (44.1)                40 (70.7) 
Age ,mean years ± SD                               25 .3 ± 5.2                 24.3± 4.7                       26.1± (5.4)                          0.017* 
Number of living children  mean value ± SD    1.4 ± 1.2           1.1 ± 1.1                        1.8 ± (1.3)                           0.001 ş    
 Education, years                                                           
        0-7                                            54/281(19.1)         54/295(18.3)                 10 (17.2)              
       8-11                                             224/281(79.4)        233/295(79.0)               47(81.0)                              0.841 
       >12                                                           4/281(1.4)            8/295(2.7)                            -    
 Marital status    
     Married                                                   246/272(90.1)        275/294(93.5)                  49 (87.5)                           0.191 
     Single                                                       27/272 (9.9)           19/294 (6.5)                      9 (12.5) 
 Formally employed                                      18/285(6.3)           14/295(4.7)                        6 (10.3)                          0.379 
Omega 3 supplement in –take                       54/287 (14.2)       30/299 (10)                         9 (15.5)                          0.002^   
 
Ω
 participants who either refused to further take part in the study, moved to a distant province or whose whereabouts could not be 
verified. 
* Participants versus those children who died. 
ş   Participants versus lost to follow up or died. 
^ Participants versus lost to follow up 
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4.1.2          CHILD MORTALITY DURING FOLLOW UP PERIOD 
 
A total of 58 children, who had been assessed for neurodevelopment in infancy were, 
reported to have died during the 5 year follow up period. Thirty four of the deaths (34/58) 
occurred after the first year of life. 
 
  Figure 4         Trends in child mortality by maternal HIV status 
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In this cohort, beyond the age of 4 months, maternal HIV status and infants `classification 
into the high risk group for poor development was significantly associated with higher 
mortality (Table 3). 
 
Table 3    Enrolment characteristic, maternal HIV status and neurodevelopmental 
outcomes in infancy of the 58 children who died during the follow up period. 
Infant 
characteristic 
Total                        Deceased P value 
Number % 
Birth weight 
   < 2500  
    >2500    
 
 Sex       
    Male 
    Female   
Nevirapine 
prophylaxis 
    No 
   Yes 
Maternal HIV 
    HIV infected 
    HIV  uninfected 
 
 High risk for poor 
neurodevelopment 
by BINS test     
No 
Yes                                                                      
 
                                       
      
                                                                       
 
53 
512 
 
 
 
296 
305 
 
 
 
394 
250 
 
 
 
321 
323 
 
 
 
 
 
610 
 34 
 
 
3 
53 
 
 
 
28 
30 
 
 
 
28 
30 
 
 
 
41 
17 
 
 
 
 
 
50 
8 
 
5.7 
9.6 
 
 
 
9.3 
9.6 
 
 
 
7.1 
12 
 
 
 
12.8 
5.3 
 
 
 
 
 
8.2 
23.5 
 
 
0.459 
 
 
 
0.127 
 
 
 
 
0.035 
 
 
 
 
 
0.001 
 
 
 
 
 
0.02 
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4.2   SOCIO-DEMOGRAPHIC CHARACTERISTICS OF PARTICIPANTS 
The children`s primary care givers were predominantly biological parents in both groups. 
Extended family members included grandparents, aunts and uncles .Only one participate 
was living in a household headed by his fourteen year old sibling. None of the children in 
this study were institutionalized. Socio-demographic characteristics were comparable 
between children with HIV infected and uninfected mothers. 
 
Table 4 Description of child care giver at the examination of 278 preschool children by 
Maternal HIV status 
Maternal HIV status                         HIV-1 Negative                     HIV-1   Positive   
                                                           N=138 (%)                            N=140 (%)             P value 
 
Principal primary care giver   
   Biological Parents                           120 (87.0)                             123 (87.2)                     0.821            
   Extended family members                18 (13.0)                              17 (12.1)                    
 Age , mean years± SD                        30.6± (9.9)                          31.9±  (9.4)                   0.274 
 Male sex                                                2 (1.4)                                5 (3.6)                          0.447 
 Education, years 
      No formal education                        2 (1.4)                                 1 (0.7)                          0.198 
      0-7                                                19 (13.8)                     32 (22.6)                   
      8-11                             114 (82.6)                             106 (75.9) 
       >12                                 3 (2.2)                                  1 (0.7)    
   Occupation 
     Not employed                                 63/125(50.4)                     50/119(42.7)                  0.39 
     Self employed                                 53/125(42.4)                     57/119(46.8)  
     Formally employed                   9/125(7.2)                       12/119(10.5) 
Total family income 
  < $ 30 per month                                81(58.7)                            95(67.9)                        0.277 
  >$ 30 per month                                 29(21)                               24(17.1)  
  Refused to answer                              28(20.3)                           21(15.0)    
Household characteristic 
    Own house                                       32 (22.4)                             39 (27.9)                    0.372 
     Rented house                                 106 (76.8)                           101 (72.1)  
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The 278 children born to HIV negative and HIV positive mothers were similar in socio-
demographic characteristics and neurodevelopmental High risk classification according 
to BINS test. Less mothers in the HIV infected group compared to the HIV uninfected 
had opted to breast feed. 
 
 There were 36 orphaned children in the cohort. Children in whom both parents had died 
(double orphans) were 6 whilst 30 were single orphans: 23 with father only deceased and 
7 with mother only deceased. 
 
Table 5   Socio-demographics, health, neurodevelopment risk and HIV status of 278 
preschool children (aged 3 ½ - 5 ½ years). 
Maternal HIV status                               HIV-1 Negative                 HIV-1   Positive   
                                                                                N=138 (%)                         N=140 (%)                                        P value  
 Age , mean months± SD                         56.1 ± 7                    56.14 ±  6.1     0.851 
 Male sex                                                 59(42.8)                     66 (47)                                     0.462   
 Formal preschool attendance                  36(30.5)                    35 (29.6)                                  0.921 
Breast fed                                                132(98)                    122 (88)                                     0.001 
Orphan hood                                            N=10  N=26 
    Mother  deceased                                    3(30)                        4 (15)                                     0.550 
    Father deceased                                      6(60)                      17 (65.4) 
    Both parents deceased                            1(10)                        5 (19.2) 
 *Morbidity   in past  3 months                     70 (51.6)                 86  (62.3)                                  0.081 
High risk score on BINS   test in infancy    5(3.6)                      8(5.7)                                     0.572 
Child HIV status 
   HIV infected                                               0                           25   
   Seroreverter                                                0                            94 
   Uninfected born to HIV infected           126                               0 
   *Unknown status                                          0                          33     
 
 
* Unknown HIV status refers to those children born to HIV positive mothers who were 
not tested during follow up period. 
* Morbidity refers to the occurrence in the previous 3 months of any of the following 
illnesses: cough, diarrhea, fever, ear discharge, vomiting or admission to hospital with 
any other diagnosis. 
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4.3   HEALTH STATUS 
 
At least 30% (85/278) of the children in this cohort were stunted, while 45 (16%) were 
underweight. Children infected with HIV were more stunted compared to their peers in 
the seroreverter or HIV Negative groups. Lymphadenopathy and skin disorders were 
significantly more frequent in HIV infected children compared to children in the 
serorevertor or HIV negative groups. 
 
Table 6 Comparison of clinical examination of 278 preschool children stratified by 
maternal [M] and child [C] HIV status: HIV positive (M+C+),HIV negative 
(Seroreverters [M+C-]) and control (M-C-). 
 
Child indicator HIV infected HIV uninfected Unknown 
status 
N=33 
P value 
M+C+ 
N=25 
M+C- 
N=94 
M-C- 
N=126 
Morbidity    16/25 (64) 58/93(62.4) 66/123(53.7) 16/32(50) 0.425 
Lymphadenopathy 13/24( 56.5)       11/85 (12.9) 11/85 (12.9) 3/31 (9.7) 0.001 
Skin disorders                             9/22 (40.9)          9/84 (10.7)      19/119(16.0) 3/13  (13.3) 0.007 
Dental Caries 3/22 (13.0)           4/78 (4.8) 3/118 (2.5) 4/30 (13.3) 0.70 
Neurological  Examination 
   Abnormal 
 
0 
 
1 
 
1 
 
0 
 
Anthropometric 
  Height 
  HAZ < -2SD                             
 
 
11/20 (55) 
 
 
28/87(32.2) 
 
 
36/117(32.5) 
 
 
10/30(33)                  
 
 
0.050 
Weight 
      WAZ < -2SD 
 
5/22 (22.7) 
 
18/82(23.2)          
 
18/109 (16.5)           
 
4/27(14.8) 
 
0.603 
Head circumference 
      HCZ < -2SD                         
 
2 
 
0 
 
2 
 
1 
 
Stunted; height for age less than 2 standard deviation of mean 
Underweight; weight for age less than 2 standard deviation of mean 
Small head size; head size in centimeters less than 2 standard deviation of mean for age(50) 
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Paediatric HIV clinical staging 
Fifteen of the twenty five HIV infected children were clinically asymptomatic (60%, 
[0.41-0.79] 95% confidence interval), while ten has symptoms of progressing disease 
(40%, [0.21-0.59] 95 confidence interval) and were referred for initiation of antiretroviral 
therapy at the tertiary hospital. 
 
 
 
Figure 6 Clinical profile of 25 HIV infected children (M+C+) by WHO paediatric 
clinical staging. 
 
 
 
Definition of WHO paediatric clinical staging of HIV / AIDS for children with confirmed 
HIV infection: Stage 1= asymptomatic; Stage 2= mild symptoms; stage 3=advanced 
symptoms; stage 4 =severe symptoms. 
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4.4 NEURODEVELOPMENT AT PRESCHOOL AGE 
 
MSCA was completed by 278 children .The age corrected GCI scores for the total sample 
ranged from 64 to 136 (mean104; SD 13.9).  
The means in GCI for the 4 different groups according to the child `s HIV status were all 
within the normal range compared to the standardization population (Table 7). 
Contrary to our hypothesis, there were no significant group difference in the global 
cognitive function between the HIV infected and HIV uninfected children. However, 
some focal differences were evident in word knowledge, numerical memory, verbal 
fluency, counting and sorting and conceptual grouping subtests between the seroreveter 
and HIV negative groups. Children in the seroreverter group had lower scores compared 
to children in the HIV uninfected group.  There was no significant difference in subtest 
means between the HIV infected and HIV uninfected. Child HIV clinical stage was not 
associated with lower GCI scores in this cohort. 
 
 Table 7  Age adjusted Subtest scores and GCI according to Kaufman short form MSCA, 
means , standard  deviations, for children aged 3  ½  to 5 ½  years by child HIV status. 
 HIV infected HIV uninfected Unknown 
status 
N=33 
P value 
M+C+ 
N=25 
M+C- 
N=94 
M-C- 
N=126 
Scale/Subtest                     Mean + SD Mean + SD Mean + SD Mean + SD  
GCI 100.6 (14.6) 103.7(14.2) 104.8 (14) 108.4 (13.21) 0.195 
Total Weighted Scores         48.1 (12.5) 47.1 (12.7) 54.7 (13.5)  51.4 (13.5) 0.001 * 
Puzzle Solving[27] 0.8 (0.8) 0.8 (1.1) 1.1 (1.2)                                  1.2 (1.1) 0.201      
Word knowledge [29] 21.5 (4.5) 20.4 (5.3) 22.3 (4.1) 21.5  (3.9) 0.043  *   
Numeric Memory  [12]             5.6 (2.3)                   5.7 (2.5) 6.7 (2.6)                                 6.5 (2.3) 0.029* 
Verbal fluency  [36] 14.1 (4.8) 13.1(4.7) 14.7 (4.6) 15.7 (5.8) 0.018* 
Counting  and Sorting[9]  4.3 (2.7)                  4.1 (3.5) 5.7(2.78) 4.8  (2.8) 0.001* 
Conceptual  Grouping  [12]     2.8 (2.0)                  3.3(3.8)                          4.3 (3.4) 4.8 (3.8) 0.026 *                                 
[ ] denotes optimum weighted score for each subtest 
 
*      Post hoc test,   HIV negative versus seroreverter                 
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 4.4.1 Growth and cognitive performance at preschool age 
 
The results show a trend towards lower scores on GCI if growth is retarded. In this study 
children who were stunted had significantly lower means compared to those with normal 
height for age. This difference persisted when HIV status was considered. 
 
Table  8  Means and standard deviations on Kaufmann short form MSCA for preschool  
              children with and without growth restriction  according to WHO growths charts  
 
 
                   General Cognitive Index  
Number           Mean                    +  SD                P value  
Height 
    Stunted 
    Normal 
Weight 
    Underweight 
    Normal Weight 
Head circumference 
     Small head size 
     Normal head size 
 
85                             99.7                        13.0                         <0.0001 
170                         107.7                       13.5 
 
46                           102                            13.4                           0.197 
196                         105                        14.3 
 
5                              99.2                          21.6                          0.409 
225                          104                       14.0 
         
Stunted; height for age less than 2 standard deviation of mean 
Underweight; weight for age less than 2 standard deviation of mean 
Small head size; head size in centimeters less than 2 standard deviation of mean for age(50). 
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4.4.2   Cognitive impairment 
 
Based on the McCarthy Scales Children Abilities ` estimated General Cognitive Index, 
twenty 24 children (8.6 %) had a score less than 1 SD of the mean for age and were 
classified as cognitive impaired, 204(73%) had a normal cognitive score, and 50(18%) 
had a superior cognitive score. 
 
Tables 9 and 10 show child cognitive impairment was significantly associated with, 
maternal younger age, low family income and living in rented lodgings. Children who 
were stunted or had a small head size for age, showed a trend towards being more 
cognitive impaired compared to children with normal growth. 
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Table 9   Assessment   of cognitive impairment in children aged 3 ½ to 5 ½ years (n=24)       
          and its association with child care giver socioeconomic characteristics. 
 
Factor Total  
Number 
 
 
N=278 
Number 
with 
cognitive 
impairment 
N=24 
P value CRUDE Adjusted 
Ω
 
OR 95 % CI OR 95% CI 
Maternal age ,years 
  < 19 
   >20  
 
43 
235 
 
 
  8 
16 
 
 
0.011 
 
 
2.7 
1 
 
 
1.2- 5.9 
 
 
21 
 
 
2- 202 
 
Principal care giver 
 Biological parents 
 Extended family 
 
243 
35 
 
 
22 
2 
 
 
0.75 
 
 
1 
0.6 
 
 
 
0.2- 2.5 
 
 
- 
 
- 
Education,   maternal  
 <  7 years 
>7 years 
 
 223 
   55 
 
18 
6 
 
0.50 
 
 
1.4 
1 
 
0.6- 3.4 
 
- 
 
- 
Occupation, caregiver 
   Not employed 
  Employed 
 
112 
131 
 
13 
 9 
 
0.2 
 
1.7 
1 
 
0.7- 3.7 
 
- 
 
- 
Income 
  < 30 USD/month 
  >30 USD/ month 
 
176 
53 
 
 
19 
1 
 
0.05 
 
 
5.7 
1 
 
0.7- 41 
 
- 
 
- 
Home ownership 
 Own house 
 Rent house 
 
71 
205 
 
2 
22 
 
 
0.049 
 
1 
3.8 
 
 
0.9- 15 
 
 
- 
 
- 
Marital status 
 Single 
 Married  
 
28 
240 
 
1 
22 
 
0.485 
 
0.4 
1 
 
0.05- 2.7 
 
- 
 
- 
Maternal HIV  
    Infected  
   Uninfected 
 
  140 
    38 
 
10 
14 
    
  
0.373 
 
0.7 
1 
 
0.7- 3.1 
 
 
- 
 
- 
Cognitive impairment defined by GCI score < 1 standard deviation of mean 
Ω Adjusted for family income, maternal HIV infection and marital status 
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Table  10   Assessment   of cognitive impairment in children aged 3 ½ to 5 ½ years    
                  (n=24) and its association with child anthropometric outcomes, early    
            neurodevelopment assessment HIV status, and sociodemographics characteristics. 
Factor Total  
Number 
N=278 
Number with cognitive 
impairment 
N=24 
P value Crude ODDS       95% CI 
Gender 
Boy  
Girl 
 
125 
153 
 
14 
10 
 
0.168 
 
 
1.7 
1 
 
0.8-3.7 
Birth weight 
<2500 
>2500 
 
20 
220 
 
  4 
20 
 
0.12 
 
 
2.2 
1 
 
0.8-5.8 
Nevirapine prophylaxis 
 No  
 Yes 
 
158 
119 
 
16 
8 
 
0.319 
 
 
1.51 
1 
 
0.6-3.4 
 
Preschool attendance 
 No  
 Yes 
 
164 
71 
 
15 
3 
 
   0.286 
 
2.2 
1 
 
0.7-7.2 
Child HIV Status 
 HIV infected 
 HIV seroreverter 
 HIV negative 
Unknown status 
 
25 
94 
126 
33 
 
2 
7 
12 
3 
 
0.85 
 
 
0.8 
0.8 
1 
0.9 
 
 
0.2-3.5 
0.3-2 
 
0.3-3 
 
High risk in infancy 
 No  
Yes  
 
265 
13 
 
23 
1 
 
1 
 
1 
0.9 
 
0.1-6 
Arthropometric 
 Height ,stunted 
  No 
  Yes 
 
170 
 85 
 
9 
10 
 
0.064 
 
1 
2.2 
 
0.9-5.2 
 
Weight ,underweight 
  No 
  Yes 
 
196 
46 
 
16 
4 
 
1 
 
1 
1.1 
 
0.4-3 
 
Head circumference 
    < 2SD 
         >2SD 
 
5 
 255 
 
 
2 
 21 
 
0.064 
 
4.9 
1 
 
1.5-15 
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4.5 Comparison of GCI mean scores based on BINS risk grouping 
Only thirteen children classified as high risk according to BINS classification were 
evaluated at preschool age, 8 of whom were born to HIV infected mothers.  
 
  Table 11 Infants neurodevelopment outcomes according to BINS risk classification at 
baseline (3 to 15 months) for the 278 preschool children. 
 
BINS risk Maternal uninfected 
N (%) 
Maternal infected 
N (%)                                       P value 
3-4 months 
   Low 
   Moderate 
   High 
 
74(94) 
4(5.1) 
0 
 
90(82.6) 0.036 
17(15.6) 
   2(1.8) 
7-10 months 
  Low 
  Moderate 
  High 
 
 
44(58.7) 
26(34.7) 
  5(6.7) 
 
67(61.5)                                 0.811 
37(33.9) 
  5(4.6) 
11-15 months 
   Low 
   Moderate 
   High 
 
 
13(46.5) 
15(53.6) 
- 
 
9(52.9)                                  0.287 
6(37.5) 
1(6.2) 
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Preschool outcome on the GCI mean scores were compared with the three BINS risk 
groupings: Low risk, Moderate risk, and High risk in infancy (Table 8). Differences in 
mean scores between the BINS groups, were significant in the HIV infected group, only 
at the 3 -4 month assessment .Significant variation was in the Low and Moderate risk 
groups. The difference disappeared at late examinations (7- 10 months and 11 -15 
moths). 
 
Table12 Comparison of GCI mean scores at preschool age with BINS risk grouping  in 
infancy  by child HIV status.  
BINS Child (M+C+)     
GCI  ,mean +  SD          
P value   Child(M-C-)   
GCI,mean  + SD  GCI 
P value 
3-4 month 
  Low risk 
  Moderate risk 
  High risk 
7 -10 month  
  Low risk 
  Moderate risk 
  High risk 
11 -15 months 
   Low 
   Moderate 
   High 
 
 
104(13.3) 
100(6.9) 
64 
 
104(14.3) 
98(16.1) 
92 
 
110 (14) 
96 (22) 
 92 
 
0.031 
 
 
 
0.219 
 
 
 
0.58 
 
 
 
 
 
104(14.1) 
194(6.9) 
- 
 
110 (13.6) 
103(15.4) 
102(14.0) 
 
101(15.8) 
101(7.4) 
- 
 
0.14 
 
 
 
0.161 
 
 
 
0.88 
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Two level risk grouping (highrisk, lowrisk) 
In the total cohort, children in the High risk at each group of the three ages had lower 
GCI scores than those in the Lowrisk group, though not statistically significant (Table13). 
 
Table 13 Comparison of two level risk grouping BINS highrisk and lowrisk versus GCI 
mean scores in 278 preschool children  
 
 General Cognitive Index 
Mean (SD)                     P value                   
3-4 month 
Lowrisk 
 Highrisk 
7 -10 month 
       Lowrisk 
      Highrisk 
11 -15 month 
    Lowrisk 
    Highrisk 
 
 
 104 (22)                          0.113 
   93(14.1)                  
 
105 (14.5)                         0.74              
105 (14.3)                 
                                       
 
 
 101(10.1)                          0.671    
 99 (14.2)               
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Children falling into the highrisk and lowrisk BINS status classification at 3-4, 7-10 and 
11-15 months were compared  with regards their preschool cognitive outcome (MSCA 
GCI >1SD below average  was considered cognitive impaired). Cognitive impairment 
was frequent in the highrisk compared to the lowrisk group at preschool age, although not 
statistically significant. (Table 14). 
Table 14 Comparison of the BINS highrisk and lowrisk grouping by Cognitive 
impairment in 24 preschool children. 
 
 Total Number  Number with 
cognitive impairment 
          P value ODDS CI 
3-4 month    
    Highrisk 
     Lowrisk 
7 -10 month 
    Highrisk 
    Lowrisk 
11 -15 month       
      Highrisk 
     Lowrisk 
 
4 
184 
 
39 
145 
 
8 
36 
 
1 
15 
 
3 
10 
 
1 
4 
 
 
 
0.301 
 
 
1.00 
 
 
1.0 
 
3.0 
1 
 
1.1 
1 
 
1.1 
1 
 
0.5-17.9 
 
 
0.3-3.8 
 
 
0.4-8.7 
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When the  BINS summary (total of raw scores as a continuous scale ) and risk status 
groping were correlated with the preschool age McCarthy  Scales GCI, association were 
only found if the the child had been assessed  at the 3-4 month time  period and the child 
HIV infected. The correlation was in the moderate range (Table 15). 
 
Table 15 Correlation between BINS total of raw scores as a continuous scale and risk 
status grouping versus GCI outcome in 278 preschool children. 
 
 Child (M+C+)     
Correlation coefficient 
  Child (M-C-)   
Correlation coefficient  
BINS 3-4 
  Score 
  Risk 
BINS 7-10  
  Score 
  Risk 
BINS 11 -15 
  Score  
  Risk 
 
 
0.62b 
-0.54a 
 
0.18 
-0.24 
 
-0.52 
0.29 
 
BINS 3- 4 
Score  
Risk 
BINS 7-10 
Score 
Risk 
BINS 11-15 
Score 
Risk 
   
    0.21 
   -0.17 
 
  0.19 
-0.22 
 
-0.04 
 0.03 
 
a
P<0.05 
b
P<0.01 
 
 
 
 
 
 
 47 
CHAPTER.5   DISCUSSION 
This study provides data on Zimbabwean preschool aged, HIV type 1 vertically infected 
children followed from birth for neurodevelopment and whose mothers participated in a 
national PMTCT program. The primary finding was that preschool aged vertically 
infected HIV children showed normal global cognitive function on Kaufmann short form 
of MSCA. This contrast with our hypothesis that there would be significant group 
difference in the global cognitive function between the HIV infected and HIV uninfected 
children with HIV infected performing lower GCI scores. Studies conducted early in the 
HIV epidemic described children characterized by lower scores on global function related 
to the degree of encephalopathy in infancy(51-53).  
 
Our findings confirms results from previous research(7;8;39;54;55). A study 
investigating the effect of HIV on cognitive abilities showed that children without AIDS 
defining illness performed as well as uninfected children. However  the children in that 
study were also receiving anti retroviral treatment (54), unlike in this series where HIV 
infected children were predominantly asymptomatic and not on treatment. 
 
Significant focal differences were evident in the subtests of the MSCA, in particular word 
knowledge, numerical memory, verbal fluency, counting and sorting and conceptual 
grouping between the seroreveter and HIV negative children, but no difference between 
the infected and uninfected children.These subtests represent verbal, perceptual and 
quantitative performance on the full scale McCarthy. Specific cognitive impairments 
associated with HIV infection have been identified in previous research. These include 
visuospatial , motor integration, language impairment, sequential processing and adaptive 
functioning(56). Boivin in former Zaire, conducted research on asymptomatic HIV 
infected children and had with similar findings to our study. In that series their findings 
indicated lower scores in sequential processing, spatial memory and auditory and visual 
recall(12). The poorer performance by seroreverters in this study on the subtests of 
MSCA may be a reflection of the harsh home environment defined by having close 
family members, particularly the mother succumb to HIV related illness.  
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Partial explanation for the pathophysiolgy on the relation between HIV and cognitive 
function has been provided by neuro-imaging research. Neuro-imaging studies conducted 
on HIV infected children already on highly active antiretroviral therapy  (HAART)  have 
documented changes in the immature  central nervous system, in particular the pyramidal 
tract, basal ganglia, frontal and prefrontal areas of the brain (40;57). Myelinopathy 
resulting from HIV infection has been implicated in cognitive, visuomotor, language  and 
behavioral delays which become more prominent over time (58). Since no neuro-imaging 
was assessed in any of the children in this cohort, we were unable to determine whether 
there is structural brain changes associated with cognitive deficits.  
 
Neurological compromise associated with paediatric HIV infection is hypothesized to be 
related to the direct effects of the virus on the neural tissues. The resultant CNS 
dysfunction manifests as HIV related encephalopathy of the progressive or static 
type.(55;58). Progressive encephalopathy, the worse type, is associated with impaired 
brain growth, loss of developmental milestones, spasticity and behavioral disorders. In 
static encephalopathy, there is no insidious deterioration of attained milestones; however 
acquisition of new skills occurs at a much slower rate for the child `s age. Cognitive 
impairment in children with static encephalopathy has been reported to range from low to 
average and high. Static encephalopathy as opposed to progressive encephalopathy has 
been observed in older children(55). We did not observe significant differences in motor 
deficits in this study. It is likely that the more affected infants with progressive 
encephalopathy from our cohort probably did not survive into childhood.  
 
Our cohort represents children who survived to preschool age in the absence of highly 
active antiretroviral drugs. Various factors have been put forward to explain the survival 
selection including maternal host factors, infant host factors, viral phenotype, viral load 
CD4 counts, timing of transmission and disease stage. Infants with intrauterine infection 
were documented to have rapid disease progressive than children with intra or post 
partum infection(10;59). Infection by a less virulent HIV type 2 is another possibility. 
Although no studies have documented sole HIV type 2 infection in  the Zimbabwean 
population, between 18 to 25% of HIV infected adults had dual infection with  HIV 1 and 
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HIV 2 in a surveys  conducted in Zimbabwe (60). There is no data on the association of a 
dual infection on child cognitive function. The child survivors in this study may reflect 
those children with the less aggressive disease. 
 
We acknowledge that the Kaufmann short form of MSCA was modified and adopted for 
this study at the expense of sensitivity to identify children with cognitive impairment. 
There is no gold standard cognitive assessment tool standardized for Shona speaking 
Zimbabwean children. The computed GCI from the subtests of the short form of MSCA 
may not be the most sensitive and specific test to identify subtle differences in the global 
cognitive performance of preschool children. It is possible that the research tool was low 
in sensitivity to detect rare cognitive impairment in this cohort. 
 
The number of surviving HIV infected children in this cohort was relatively small (n=25). 
This may have resulted in the study being low powered to detect very small differences 
between the group means. Other factors that explain absence of variability in cognitive 
performance in this cohort may be related partly to the medical, educational, and social 
support the children and their families received through their participation in this study.  
 
In this study, 24 children (8.6%) were identified as cognitive impaired: 8.3% among the 
HIV positive children; 7.4 % among the seroreverter; 9.5% among the HIV negative and 
9.1% among those with unknown status. Family income of less than 30 US dollars per 
month, a teenage mother and renting a house was associated with cognitive impairment in 
this cohort. Among the same children, earlier neurodevelopment assessment using BINS 
has estimated neurodevelopment impairment during infancy at 5.2%. The prevalence of 
cognitive impairment in this cohort is high. Previous studies in have documented 
cognitive impairment ranging from  6.2 to 40% (9;13;51;53).This discrepancy in reported 
prevalence is due to the variability in methodology between the different studies and 
differences in the study populations. The prevalence of  neurodevelopment impairment at 
age 2  year was  9% in a study conducted in Rwanda and this  compares with  our 
findings(61). In another research conducted in Tanzania, among a low HIV prevalence 
population, the prevalence of neurodevelopment impairment in infants was 6.2%. In both 
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studies however neurodevelopment impairment was more frequent in the HIV positive 
infants compared to the HIV negative. The relatively high prevalence among the HIV 
uninfected in our cohort might have been confounded by survival bias were the infected 
children with severe disease probable died. It is plausible that there are other factors such 
as socioeconomic status, nutrition or home environment that are influencing cognitive 
abilities at preschool age even in the HIV uninfected children. 
 
Proxy measures for socioeconomic status (house ownership and income less than 30 US 
dollars per month) in this study were significantly associated with cognitive impairment. 
Research has implicated a relationship between socioeconomic status and cognitive 
ability in children. A longitudinal study conducted in Ecuador  investigating the effect of 
iron deficiency on cognitive function found an association  between low socioeconomic 
status and cognitive scores(62). A study by Coscia et al established that the quality of the 
home environment  mediated the relationship between socioeconomic status and child 
cognitive function(22) while a study conducted in Kenya among children under 3 years 
living in poverty reported anthropometric measures such as height and weight as 
mediators of the relationship between socioeconomic status and psychomotor 
development(63). 
Regrettable we did not assess the effect of home environment on cognitive function in 
this study due to time and financial constraints. Based on a commonly used scale The 
Home Measurement of the Environment Inventory(64), it is possible to observe and 
evaluate home organization, play materials, parental involvement and variety of 
stimulation each child receives. These provide valuable information on provision of 
cognitive stimulation or education in the home. Only 71 (25.5%) of the children in this 
cohort were attending formal preschool despite early child learning services being offered 
for free at public schools in Zimbabwe. 
 
Families living with extended family members are common in African populations. In 
addition to the social support provided by such structures, children reared in such adult -
rich environments appear to get more cognitive stimulation and have higher scores on 
intelligence test compared to children living in homes with few adults. In a study to 
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predict cognitive,  adaptive and behavioral function in preschool children with HIV,  a 
low child to adult ratio was predictive of  better scores on cognitive test(65).The child 
adult ratio was not examined in this study. 
 
HIV infected children in this cohort had more skin disorders and generalized 
lymphadenopathy compared to their uninfected peers, probably as reflection of their 
compromised immune function. Of concern more than 50 %( 155) of all the children in 
this cohort reported a history of serious illness in the preceding 3 months. This may 
indicate that the children in this population are still at risk of determinants of child 
morbidity and mortality experienced by children from low socioeconomic background 
and may confound the relationship between HIV and cognitive function. 
 
Forty-six children (16%) in this cohort were underweight. World Health Organisation, in 
1999 estimated the prevalence of underweight in Zimbabwean under 5 year olds at 
11.2%. In a study conducted in Zimbabwe investigating seasonal variability of the 
prevalence of underweight within a clinic based growth monitoring programme, the 
prevalence of underweight among children less than 5 years ranged 10.7 to 11.2. Our 
prevalence of underweight is higher than the estimated national figure. Possible 
explanations for the discrepancy is the current worsening in country`s economic 
environment resulting in less family resources being allocated for nutritional needs. Most 
families are either infected or affected by HIV infection, which may result in funds being 
channeled towards the caring of the sick parents or guardians at the expense of feeding 
the family. In this study underweight was not associated with cognitive impairment, 
partly be due to the small sample size which made the study weakly powered to detect 
small differences between groups. Studies in other developing countries have different 
findings(63;66-68) where being underweight was related to lower cognitive scores. 
 
In agreement with our earlier observations(17), the mortality rate  in this cohort was 
higher  among HIV infected children compared to the uninfected .Other studies have 
documented similar findings(59) with crude mortality ranging 10 to 40 % (53;69;70).  
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The third objective of this study was to compare cognitive function at preschool age with 
neurodevelopment outcome according to BINS risk grouping: High, Moderate and Low.  
In this cohort, we observed a trend for high risk classification being related to lower GCI 
scores at preschool age. Similar results were documented in a study by Aylward(71). In 
the HIV infected children, the differences in GCI means between the 3 BINS risk groups 
were statistical significant if the infants were examined between 3 to 4 months of age 
compared to the ages 7 to 10 months or 11 to 15 months. The short form MSCA seemed 
to fit according to BINS classification, particularly for the HIV infected children. The 
aim of neurodevelopment screening in infancy is to distinguish infants with current 
developmental problems and predict those who at risk for neurodevelopment impairment 
later. To this end, we have identified the period 3 to 4 months as a possible window of 
opportunity to initiate neurodevelopment screening for children exposed to perinatal HIV 
infection and coming from predominately breast feeding population.   
 
We could not prove if BINS risk classification in infancy predicts cognitive impairment 
at the ages 3 ½ to 5 ½ years in this cohort although children in the High risk group in 
infancy manifested more cognitive impairment at preschool age. Adaptation we made to 
the Kaufmann short form of MSCA might have influenced the reliability of the scale 
underestimating the strength of the relationship between the BINS and MSCA tests. Due 
to the relatively small sample size and few children with high risk in infancy who took 
the MSCA later at preschool age, this study is weakly powered to detect very small group 
differences between early and later neurodevelopment assessments. Interpretation of our 
findings on the predictability of the BINS test for later neurodevelopment should be 
viewed with caution due survival bias. 
 
The current study has proved that it is possible to follow up child neurodevelopmental 
outcomes in resource limited setting, utilizing simple screening tools. Although 
asymptomatic surviving HIV infected children have normal cognitive function compared 
to their uninfected peers, they are more susceptible to other childhood infections and 
nutritional deficiencies. The prevalence of cognitive impairment in this cohort was high 
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underscoring the need to address those factors that negatively influence child 
development if the socio-economic potential of these children is to be realized.  
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5.1     LIMITATIONS OF THE STUDY 
1) Moderate proportions of children were lost to follow up and this might result in 
biased estimates of mean GCI. Since the two groups (participants and those lost to 
follow up) were similar in the proportion of children born to HIV infected 
mothers, it is unlikely that this would lead to a strong bias in the means. 
2) Follow up of the children was limited by the dispersion of town communities that 
took place prior to this follow up study. Families perceived to be living in urban 
slums of Chitungwiza and Epworth were forcible evicted to the rural areas and 
could not be tracked due to lack of forwarding addresses. 
3) Children biomedical profiles such as CD counts 4 and viral loads were not 
assessed, due to financial constraints. For the HIV infected children these provide 
an indication on the disease stage and can be used in the monitoring of clinical 
progress. Almost one tenth of the children born to HIV infected mother did not 
have confirmatory laboratory test. This decreased the number of children with 
known status and possible underestimated the association between HIV and 
cognitive function. 
4) The timing of child HIV infection was not examined in this study. This might 
provide answers to the variation in the pattern of cognitive function at preschool 
age. 
5) Further investigation of the components of cognitive function was not possible in 
this study because MSCA does not include a measure for home environment, 
interaction between caregiver and child or behavioral disorders. 
6)  The Kaufmann short form of MSCA was developed and validated in the United 
States and there is no normative data for MSCA in others societies.  Adaptation 
we made to the Kausman short form of MSCA might have influenced the 
reliability of the test score which might have underestimated the strength of the 
relationship between GCI and HIV infection .It is possible that some cultural bias 
in the McCarthy remained. 
7) Serial longitudinal measurements on cognitive function using of the full scale 
MSCA was not conducted for this study. Based on the Kaufmann short form of 
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MSCA the index score do not allow differentiation between  delay in achieving  
new milestones and losing previously acquired milestones 
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5.2     CONCLUSION 
The current study has proved that it is possible to screen preschool children for cognitive 
impairment in resource limited settings utilizing simple screening tools such as 
Kaufmann short form of MSCA.HIV infected children who survive to preschool age did 
not manifest lower cognitive scores than established child norms. The prevalence of 
cognitive impairment in this study was 8.6% .Chronic malnutrition as indexed by stunting 
was associated with poor cognitive function at preschool age. BINS if performed in the 
first 6 months of life, was predictive of later cognitive performance particularly in HIV 
infected children. Therefore comprehensive interventions addressing early diagnosis and 
treatment for both childhood HIV and malnutrition could result in significant 
improvement in cognitive function and later academic achievement. 
 
5.3      RECOMMENDATIONS  
The following recommendations are made to Chitungwiza and Harare Municipal Council 
health departments concerning HIV and child development. 
 
1. The expanded program of prevention of parent to child transmission of HIV 
should incorporate growth and neurodevelopmental monitoring of children using 
standardized instruments which are appropriate for the period birth to adolescence. 
Children who falter on growth or developmental milestones are identified early 
and referred for intervention and treatment. 
2. A health education policy should be developed that promotes early child 
stimulation by allocating resources and providing information to parents on how 
they can provide cognitive stimulation to their children at home.  
3. The counseling of pregnant mothers who participate for PMTCT services should 
emphasize on the importance of knowing the HIV status of the child so that 
necessary monitoring for growth and neurodevelopment is started early.  
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Further research recommendations are related to the limitation in this study: 
 
1. To validate the MSCA in Zimbabwe using another cognitive assessment test e.g.  
Kaufmann Assessment Battery for Children so that it can be used in diagnosis 
preschool and school children with cognitive impairment 
2. Determine the predictors of cognitive impairment in HIV negative preschool and 
school children. 
3. Determine factors that promote normal cognitive function in vertically infected 
children living in deprived condition .This information would be incorporated in the 
planning of targeted interventions in the care of HIV infected children.  
4. Evaluate the role of malnutrition and micronutrients deficiency e.g. iron on cognitive 
function in preschool children. 
5. Develop an extensive cultural appropriate assessment tool measuring motor, language, 
cognition and socio-emotional development. 
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APPENDIX 1     Study information and consent form 
 
 
STUDY ID NO: 
 
Title of Research: Neurodevelopment outcomes at preschool age: A 5 
year follows up study of a cohort of children born to mothers 
participating in the PMTCT program in Harare, Zimbabwe. 
 
INTRODUCTION: 
 You are invited to take part in a study organized by the University of Oslo in 
collaboration with the University Of Zimbabwe College Of Health Sciences. This is a 
follow up on the study that sought to determine if sexually transmitted infections 
increased the chance of transmission of HIV to the child and also the effect of HIV on 
neurodevelopment in infancy. Studies conducted in the developing countries and East 
Africa suggests that children‟s intelligence is negatively affected by HIV. Screening and 
early identification of developmental delay will result in referral for appropriate diagnosis 
and therapy. This study aims to describe cognitive performance , at preschool age, of 
children born to HIV infected and uninfected mothers and identify factors that may 
predict delay development .In order to track development comparison will be made with 
earlier performance as screened by the BINS. 
If you agree to take part, you will be asked to sign or fingerprint this consent form in 
front of a witness. 
Please note that: 
1) Your participation in this research is  entirely free 
2) You may decide not to take part or to withdraw from the study at any time 
without losing the benefits of standard medical care from this clinic . 
Procedures: 
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On the day that you join the study and sign the consent form .you will be asked questions 
about your child `s life and health. The child will be examined by a doctor for growth and 
development. 
Exclusion criteria: 
Although you may be willing to take part in the study the doctor may decide that your 
child is not a suitable candidate if he or she was not assessed for neurodevelopment in 
infancy. 
 
Costs:  
Neither you nor your child will pay for the examinations test or treatments that you will 
receive as a study participant. If your child needs further assessment or treatment, 
referrals will be organized for you at no cost to you. 
STUDY ID NO: 
 
The study information has been read to me and I understand the aim of the study. By 
signing/placing my thumbprint on this form I agree to participate in the study of my own 
free will. 
 
 
 
............................................                    ...........................             ..................................... 
 
Signature of participants                         Date                               Interviewer`s signature 
 
 
 
Person obtaining the consent 
 
         I testify that, to the best of my ability read and explained the information 
concerning the research study in non technical terms to (Name of participant).................... 
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I encourage him/he to ask questions and answered them to the best of my ability. 
 
 
..........................................................                                        ........................... 
            Signature                                                                          Date 
 
Participant‟s address:................................ 
                                  ................................. 
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 APPENDIX 11       Child interview guide 
NAME OF CLINIC____________________ 
 
 AGE AT VISIT (months)………… 
 
Date______________                                                 Study Identification number:         _     
                                                                                                                  
1.   Child s date of birth  / __/_ /                                                                 sex            1.boy              2. girl 
  2. How are you related to this child………………………  
  3. Who does the main care for this child  
  1. mother         2. baby sitter        3. siblings              4. others 
  4. Care taker‟s age in years……………  
  5. Care taker‟s gender……………                                         1.Male         2.Female 
  6.Care taker „s level of education  …….  .0 . No formal education 1. Primary education    
                                                                     2. Secondary education 3. Tertiary education 
  7. Care taker „s Occupation    0.Not employed 1.Formally employed 2. Self employed 
  8.   Is Father    1. Alive…     2. Dead… If dead , cause of  death ………year of death... 
 9.  Is Mother   1 . Alive       2.Dead ….If dead cause of death  .……year of death …  
 10.  In the past 3 months has the child been ill from one of these ailments   
                                                                                                                 No                 Yes                                          
11-Diarrhoea                                                                                            0                     1 
12-Vomiting                                                                                             0                     1 
13-Fever                                                                                                   0                      1   
14-cough                                                                                                   0                     1       
15 Ear discharge                                                                                       0                      1                                         
16.Any other  problems, specify ………………………………………… 
17. How many times did you feed the child in the last 24 hrs  ………….   
18.  Has child completed primary immunization course            0.No                    1.Yes                        
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PHYSICAL EXAMINATION 
19Height in cm ---                      
      20. Weight in kg…………                                   
      21. Weights/ Height-----  
      22. Head circumference------                                               
                                                                                                                   No                          yes   
 23.  Underweight                                                                    0                              1 
 24 . Stunted                                                                            0                               1 
25. General      condition                                                   0 Normal               1 Abnormal 
26. Lymphadenopathy                                                             0                               1 
27. Skin   disorder                                                                   0                               1                                   
28 If abnormal specify……………………………….. …………………………….                                               
29. Mouth    condition                                                             0                               1 
30 If  abnormal specify…………………………………………………………….. 
31. Cardio vascular System                                                        0 Normal               1.Abnormal 
If abnormal specify findings……………………………………………………….. 
32.Respiratory system                                                         0 Normal              1.Abnormal 
If abnormal specify findings……………………………………………………… 
33. Gastro-intestinal Tract                                                     0 Normal    1.Abnormal 
If abnormal specify findings………………………………………………………… 
34.Neurological Status                                                            0 Normal 1.Abnormal 
35 abnormal specify findings………………………………………………………….. 
                               36  Mental status                                                          0                            1  
                                37 Cranial nerves                                                        0                            1 
                               38  Sensation                                                               0                           1 
                               39   Muscle tone                                                          0                           1   
                               40Reflexes                                                                  0                             1  
                               41Coordination                                                           0                             1 
                                  
42. WHO Paediatric Clinical stage :                      1  .2.   3.    4.      
43 MSCA  assessment                                         Mean  GCI score…………. 
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